Your browser doesn't support javascript.
loading
Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas.
Pan, Jian; Silva, Tiago C; Gull, Nicole; Yang, Qian; Plummer, Jasmine T; Chen, Stephanie; Daigo, Kenji; Hamakubo, Takao; Gery, Sigal; Ding, Ling-Wen; Jiang, Yan-Yi; Hu, Shaoyan; Xu, Li-Yan; Li, En-Min; Ding, Yanbing; Klempner, Samuel J; Gayther, Simon A; Berman, Benjamin P; Koeffler, H Phillip; Lin, De-Chen.
Afiliação
  • Pan J; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
  • Silva TC; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Gull N; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Yang Q; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Plummer JT; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Chen S; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Daigo K; Institute of Oncologic Pathology, Medical College of Shantou University, Shantou, China.
  • Hamakubo T; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Gery S; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Ding LW; Department of Protein-protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa, Japan.
  • Jiang YY; Department of Protein-protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School, Kawasaki, Kanagawa, Japan.
  • Hu S; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Xu LY; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Li EM; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Ding Y; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
  • Klempner SJ; Institute of Oncologic Pathology, Medical College of Shantou University, Shantou, China.
  • Gayther SA; Institute of Oncologic Pathology, Medical College of Shantou University, Shantou, China.
  • Berman BP; Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China.
  • Koeffler HP; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Lin DC; Harvard Medical School, Boston, Massachusetts.
Cancer Res ; 80(13): 2722-2736, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32332020
Gastrointestinal adenocarcinomas (GIAC) of the tubular gastrointestinal (GI) tract including esophagus, stomach, colon, and rectum comprise most GI cancers and share a spectrum of genomic features. However, the unified epigenomic changes specific to GIAC are poorly characterized. Using 907 GIAC samples from The Cancer Genome Atlas, we applied mathematical algorithms to large-scale DNA methylome and transcriptome profiles to reconstruct transcription factor (TF) networks and identify a list of functionally hyperactive master regulator (MR) TF shared across different GIAC. The top candidate HNF4A exhibited prominent genomic and epigenomic activation in a GIAC-specific manner. A complex interplay between the HNF4A promoter and three distal enhancer elements was coordinated by GIAC-specific MRTF including ELF3, GATA4, GATA6, and KLF5. HNF4A also self-regulated its own promoter and enhancers. Functionally, HNF4A promoted cancer proliferation and survival by transcriptional activation of many downstream targets, including HNF1A and factors of interleukin signaling, in a lineage-specific manner. Overall, our study provides new insights into the GIAC-specific gene regulatory networks and identifies potential therapeutic strategies against these common cancers. SIGNIFICANCE: These findings show that GIAC-specific master regulatory transcription factors control HNF4A via three distal enhancers to promote GIAC cell proliferation and survival. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/13/2722/F1.large.jpg.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Adenocarcinoma / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Fator 4 Nuclear de Hepatócito / Epigenômica / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Adenocarcinoma / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Fator 4 Nuclear de Hepatócito / Epigenômica / Neoplasias Gastrointestinais Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos